MK-677 contains no growth hormone — yet in trials it nearly doubled people’s GH output. That’s the whole trick: it doesn’t add growth hormone, it switches on the system that makes your own. Understanding how it does that explains both why it works and why its effects look different from a growth hormone injection.
Below, we walk through the mechanism step by step: the receptor it hits, the two switches it flips in your brain, and what the human trials actually measured.
Key Takeaways
MK-677 doesn’t supply growth hormone — it triggers your own pituitary to release more.
It works by mimicking ghrelin at the growth hormone secretagogue receptor (GHSR-1a).
It raises GH through a two-pronged action: stimulating GH-releasing signals and easing the brake (somatostatin).
It amplifies the natural pulses of GH rather than producing a flat, artificial level.
In human trials, daily MK-677 raised mean 24-hour GH by roughly 60–95%.
Bottom line: MK-677 is an amplifier of your own GH system, not a replacement for it.
MK-677 is a secretagogue, not a hormone
The first thing to understand is what MK-677 is. It’s a growth hormone secretagogue — a compound that prompts secretion of growth hormone — not growth hormone itself (PubChem CID 178024).
That single fact shapes everything. An injection of HGH puts the finished hormone straight into your blood. MK-677 does something indirect: it sends a signal to the gland that produces growth hormone, telling it to release more. So the GH that rises is your own, made by your own pituitary.
MK-677 is a non-peptide agonist of the growth hormone secretagogue receptor (GHSR-1a) — the same receptor the natural hormone ghrelin uses (ghrelin receptor and GH release).
Ghrelin is best known as the “hunger hormone,” but one of its core jobs is stimulating growth hormone release. By binding GHSR-1a, MK-677 effectively impersonates ghrelin — and the receptor can’t tell the difference. The receptor is concentrated in two places that matter here: the hypothalamus and the pituitary gland, the brain’s GH command centre.
Step 2: It flips two switches at once
This is the heart of the mechanism. Growth hormone release is governed by a push-pull system — an accelerator and a brake:
The accelerator: GHRH (growth-hormone-releasing hormone), which tells the pituitary to release GH.
The brake: somatostatin, which tells it to stop.
MK-677 works on both levers. By activating GHSR-1a, it amplifies the GH-releasing drive (working alongside the GHRH pathway) while easing off the somatostatin brake. Pressing the accelerator and releasing the brake at the same time is why the effect on GH is so robust.
Here’s a subtle but important detail. Growth hormone isn’t released in a steady stream — your body secretes it in pulses, mostly at night. MK-677 doesn’t flatten that rhythm into a constant level. Instead, it amplifies the existing pulses — increasing how much GH is released — while broadly preserving the natural, pulsatile pattern.
That’s a meaningful difference from injected HGH, which overrides your physiology and delivers a dose-driven level independent of your body’s rhythm. MK-677 works with the system; it makes your own pulses bigger.
MK-677 enhanced 24-hour growth hormone secretion and raised IGF-I in a dose-dependent way, without disrupting normal adrenocortical function. — consistent with Copinschi et al., J. Clin. Endocrinol. Metab., 1996
How much does it actually raise GH?
The numbers from controlled human trials are consistent:
In a 7-day study in healthy young men, MK-677 produced sustained 24-hour increases in GH secretion (Copinschi et al., 1996).
In a study in healthy older adults, daily 25 mg raised mean 24-hour GH concentrations substantially and lifted IGF-1 into the young-adult range (Chapman et al., 1996).
The two-year Nass trial confirmed GH and IGF-1 rose to young-adult levels and stayed elevated.
So the effect is real, measurable, and durable — typically a 60–95% rise in mean GH depending on dose and population.
Most growth-hormone stimulators — ghrelin itself, and the GHRP peptides (GHRP-6, GHRP-2, hexarelin, ipamorelin) and GHRH analogues (sermorelin, CJC-1295) — are peptides: short chains of amino acids joined by peptide bonds.
Your digestive system is purpose-built to destroy exactly those bonds. It treats a swallowed peptide identically to a piece of steak:
Stomach: acid + the enzyme pepsin start cleaving the peptide bonds.
Small intestine: pancreatic proteases (trypsin, chymotrypsin) and intestinal peptidases finish the job, chopping the peptide into individual amino acids and tiny fragments.
The gut wall: even any surviving intact peptide is large and water-loving, so it can’t cross the intestinal lining into the bloodstream efficiently.
Net result: swallow a peptide GH secretagogue and it’s digested like food before it can ever reach the ghrelin receptor. That’s why they’re injected (usually subcutaneously) — injection bypasses the gut entirely.
Why MK-677 survives
MK-677 does the same job at the same receptor (GHSR-1a), but it’s built completely differently. It’s a non-peptide — a stable, drug-like small molecule (a spiroindoline scaffold), engineered to mimic the shape that lets GHRP peptides switch on the receptor. This is called a peptidomimetic: same function, non-peptide chemistry.
Because it isn’t made of amino-acid chains:
No peptide bonds for digestive proteases to cleave → it isn’t broken down in the stomach or gut.
Smaller and more lipophilic (fat-soluble) → it crosses the intestinal wall into the bloodstream.
Metabolically stable → it isn’t rapidly cleared, giving a long half-life (~24 hours).
The practical payoff: once-daily oral dosing
Put those together and you get the property that made MK-677 valuable:
Peptide secretagogues
MK-677 (non-peptide)
Chemistry
Amino-acid chain
Small-molecule peptidomimetic
Survives digestion?
No — cleaved by proteases
Yes — no peptide bonds
Route
Injection (subcutaneous)
Oral
Half-life
Minutes to a few hours
~24 hours
Dosing
Often multiple injections/day
Once daily
That ~24-hour half-life matters because of how IGF-1 behaves: IGF-1 integrates GH activity over time, so a single daily oral dose keeps growth hormone pulses amplified around the clock and holds IGF-1 continuously elevated — no injections, no multiple daily doses.
Does MK-677 contain growth hormone? No. It contains no GH. It stimulates your own pituitary to release more of your own growth hormone.
Does MK-677 raise GH as much as an HGH injection? They work differently. MK-677 amplifies your natural, pulsatile output and is limited by your own physiology; HGH delivers a dose-driven amount directly. MK-677’s rise is significant but governed by your body’s own controls.
Does the GH increase keep working over time? In trials, GH and IGF-1 stayed elevated over months to two years. The body’s feedback system still applies, but MK-677 doesn’t simply stop working after a few weeks.
Is raising GH this way safe? Raising GH/IGF-1 by any route carries consequences — raised blood sugar, fluid retention, and other effects. MK-677 is unapproved and its long-term safety in healthy people is not established.
Yes. Please visit our store or get in touch with our sales team.
The bottom line
MK-677 increases growth hormone by impersonating ghrelin at the GHSR-1a receptor, then pressing the GH accelerator and easing the somatostatin brake — amplifying your body’s own pulsatile GH release rather than replacing it. The result is a substantial, sustained, orally-driven rise in your own growth hormone and downstream IGF-1.
Because MK-677 works by switching on your own GH machinery rather than supplying the hormone, its effect hinges entirely on the compound being what it claims — and unregulated MK-677 is routinely under-dosed or counterfeited. Confirming identity and purity by HPLC and mass spectrometry before any research use is the only way to trust the result; anything beyond the lab belongs with a qualified clinician.
This article is for informational and educational purposes only and is not medical advice. MK-677 is not approved for human use. Always consult a qualified healthcare professional.
Ghrelin: Structure and Function — GHSR-1a and GH release, Physiological Reviews: https://journals.physiology.org/doi/full/10.1152/physrev.00012.2004
Copinschi et al. (1996), 7-day MK-677 on 24-hour GH profiles, IGF-I and adrenocortical function, JCEM: https://doi.org/10.1210/jcem.81.8.8768828
Chapman et al. (1996), daily oral MK-677 stimulates the GH/IGF-I axis in healthy elderly, JCEM 81(12):4249: https://academic.oup.com/jcem/article-abstract/81/12/4249
Nass et al. (2008), oral ghrelin mimetic (MK-677) in healthy older adults, Annals of Internal Medicine (PMC2757071): https://pmc.ncbi.nlm.nih.gov/articles/PMC2757071/
SARMs promise muscle gains without the side effects of steroids – but can they actually increaseyour testosterone levels? It’s a loaded question. With fitness forums buzzing and supplement companies marketing SARMs as “testosterone boosters,” the science tells a more complicated story. Let’s break it down – what happens to your testosterone during and after SARMs use, and which compounds (if …
Evidence from Human Clinical Trials TL;DR:Clinical trial data shows that RAD140 decreases natural testosterone levels through suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Despite its anabolic properties, it does not raise testosterone, and suppression has been observed even at therapeutic doses. Key Takeaways: Does RAD140 Increase or Decrease Testosterone? What Clinical Trials Say About RAD140 and …
Ever wondered how researchers actually determine Enclomiphene dosages for clinical and pre-clinical trials? It’s a combination of: In this guide, we’ll walk through exactly how researchers build dosage models, what the published papers show, how half-life influences frequency, and the frameworks labs use when designing Enclomiphene research protocols. Let’s dive in. Table of Contents Quick …
If you’ve spent any time in the SARMs world, you’ve probably seen the same debate pop up everywhere: As research study conductors, or potential candidates in approved trials, it’s important to understand the liver health concerns related to SARMs. “Are SARMs toxic to the liver?” Some people say they’re perfectly safe; others claim they cause …
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
How Does MK-677 Increase Growth Hormone?
MK-677 contains no growth hormone — yet in trials it nearly doubled people’s GH output. That’s the whole trick: it doesn’t add growth hormone, it switches on the system that makes your own. Understanding how it does that explains both why it works and why its effects look different from a growth hormone injection.
Below, we walk through the mechanism step by step: the receptor it hits, the two switches it flips in your brain, and what the human trials actually measured.
Key Takeaways
MK-677 is a secretagogue, not a hormone
The first thing to understand is what MK-677 is. It’s a growth hormone secretagogue — a compound that prompts secretion of growth hormone — not growth hormone itself (PubChem CID 178024).
That single fact shapes everything. An injection of HGH puts the finished hormone straight into your blood. MK-677 does something indirect: it sends a signal to the gland that produces growth hormone, telling it to release more. So the GH that rises is your own, made by your own pituitary.
Further context : MK677 Side Effects
Step 1: It mimics ghrelin at the GHSR-1a receptor
MK-677 is a non-peptide agonist of the growth hormone secretagogue receptor (GHSR-1a) — the same receptor the natural hormone ghrelin uses (ghrelin receptor and GH release).
Ghrelin is best known as the “hunger hormone,” but one of its core jobs is stimulating growth hormone release. By binding GHSR-1a, MK-677 effectively impersonates ghrelin — and the receptor can’t tell the difference. The receptor is concentrated in two places that matter here: the hypothalamus and the pituitary gland, the brain’s GH command centre.
Step 2: It flips two switches at once
This is the heart of the mechanism. Growth hormone release is governed by a push-pull system — an accelerator and a brake:
MK-677 works on both levers. By activating GHSR-1a, it amplifies the GH-releasing drive (working alongside the GHRH pathway) while easing off the somatostatin brake. Pressing the accelerator and releasing the brake at the same time is why the effect on GH is so robust.
Further reading : Does MK677 increase IGF1?
Step 3: It amplifies your natural pulses
Here’s a subtle but important detail. Growth hormone isn’t released in a steady stream — your body secretes it in pulses, mostly at night. MK-677 doesn’t flatten that rhythm into a constant level. Instead, it amplifies the existing pulses — increasing how much GH is released — while broadly preserving the natural, pulsatile pattern.
That’s a meaningful difference from injected HGH, which overrides your physiology and delivers a dose-driven level independent of your body’s rhythm. MK-677 works with the system; it makes your own pulses bigger.
How much does it actually raise GH?
The numbers from controlled human trials are consistent:
So the effect is real, measurable, and durable — typically a 60–95% rise in mean GH depending on dose and population.
Understand the difference between HGH and MK666
Why it’s taken orally and lasts
Most growth-hormone stimulators — ghrelin itself, and the GHRP peptides (GHRP-6, GHRP-2, hexarelin, ipamorelin) and GHRH analogues (sermorelin, CJC-1295) — are peptides: short chains of amino acids joined by peptide bonds.
Your digestive system is purpose-built to destroy exactly those bonds. It treats a swallowed peptide identically to a piece of steak:
Net result: swallow a peptide GH secretagogue and it’s digested like food before it can ever reach the ghrelin receptor. That’s why they’re injected (usually subcutaneously) — injection bypasses the gut entirely.
Why MK-677 survives
MK-677 does the same job at the same receptor (GHSR-1a), but it’s built completely differently. It’s a non-peptide — a stable, drug-like small molecule (a spiroindoline scaffold), engineered to mimic the shape that lets GHRP peptides switch on the receptor. This is called a peptidomimetic: same function, non-peptide chemistry.
Because it isn’t made of amino-acid chains:
The practical payoff: once-daily oral dosing
Put those together and you get the property that made MK-677 valuable:
That ~24-hour half-life matters because of how IGF-1 behaves: IGF-1 integrates GH activity over time, so a single daily oral dose keeps growth hormone pulses amplified around the clock and holds IGF-1 continuously elevated — no injections, no multiple daily doses.
Further learning : What is MK677?
Frequently asked questions
Does MK-677 contain growth hormone?
No. It contains no GH. It stimulates your own pituitary to release more of your own growth hormone.
Does MK-677 raise GH as much as an HGH injection?
They work differently. MK-677 amplifies your natural, pulsatile output and is limited by your own physiology; HGH delivers a dose-driven amount directly. MK-677’s rise is significant but governed by your body’s own controls.
Does the GH increase keep working over time?
In trials, GH and IGF-1 stayed elevated over months to two years. The body’s feedback system still applies, but MK-677 doesn’t simply stop working after a few weeks.
Is raising GH this way safe?
Raising GH/IGF-1 by any route carries consequences — raised blood sugar, fluid retention, and other effects. MK-677 is unapproved and its long-term safety in healthy people is not established.
Can you buy MK677 in the UK?
Yes. Please visit our store or get in touch with our sales team.
The bottom line
MK-677 increases growth hormone by impersonating ghrelin at the GHSR-1a receptor, then pressing the GH accelerator and easing the somatostatin brake — amplifying your body’s own pulsatile GH release rather than replacing it. The result is a substantial, sustained, orally-driven rise in your own growth hormone and downstream IGF-1.
Because MK-677 works by switching on your own GH machinery rather than supplying the hormone, its effect hinges entirely on the compound being what it claims — and unregulated MK-677 is routinely under-dosed or counterfeited. Confirming identity and purity by HPLC and mass spectrometry before any research use is the only way to trust the result; anything beyond the lab belongs with a qualified clinician.
This article is for informational and educational purposes only and is not medical advice. MK-677 is not approved for human use. Always consult a qualified healthcare professional.
Sources
Related Posts
Do SARMs Increase Testosterone? Here’s What the Research Actually Says
SARMs promise muscle gains without the side effects of steroids – but can they actually increaseyour testosterone levels? It’s a loaded question. With fitness forums buzzing and supplement companies marketing SARMs as “testosterone boosters,” the science tells a more complicated story. Let’s break it down – what happens to your testosterone during and after SARMs use, and which compounds (if …
Does RAD140 Increase or Decrease Testosterone?
Evidence from Human Clinical Trials TL;DR:Clinical trial data shows that RAD140 decreases natural testosterone levels through suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Despite its anabolic properties, it does not raise testosterone, and suppression has been observed even at therapeutic doses. Key Takeaways: Does RAD140 Increase or Decrease Testosterone? What Clinical Trials Say About RAD140 and …
How to Calculate Enclomiphene Dosages: A Research-Focused Breakdown
Ever wondered how researchers actually determine Enclomiphene dosages for clinical and pre-clinical trials? It’s a combination of: In this guide, we’ll walk through exactly how researchers build dosage models, what the published papers show, how half-life influences frequency, and the frameworks labs use when designing Enclomiphene research protocols. Let’s dive in. Table of Contents Quick …
Are SARMs Hard on Your Liver? A Research-Focused Breakdown
If you’ve spent any time in the SARMs world, you’ve probably seen the same debate pop up everywhere: As research study conductors, or potential candidates in approved trials, it’s important to understand the liver health concerns related to SARMs. “Are SARMs toxic to the liver?” Some people say they’re perfectly safe; others claim they cause …